London close: Stocks finish firmer ahead of Easter break
28th Mar 2024 16:08
(Sharecast News) - London's equity markets closed higher on Thursday ahead of the Easter break, despite lingering concerns over the UK's recessionary status in the latter part of last year.
Read moreLondon close: Stocks little changed as investors look to US data
27th Feb 2024 16:05
(Sharecast News) - London's equity markets closed with a subdued performance on Tuesday, after a mixed but largely flat session trend as investors exercised caution ahead of US inflation figures later in the week.
Read moreSmith & Nephew revenue growth tops full-year forecasts
27th Feb 2024 07:22
(Sharecast News) - Medical device giant Smith & Nephew reported fourth-quarter revenue of $1.46bn on Tuesday, marking a 6.4% increase on an underlying basis compared to the prior year.
Read moreRBC sees upside risk to Q4 results at Smith & Nephew
12th Feb 2024 08:39
(Sharecast News) - RBC Capital Markets has reiterated its 'outperform' rating on Smith & Nephew ahead of the medical devices giant's fourth-quarter results later this month, saying it sees upside risk to current estimates.
Read moreLondon close: Stocks slip after surprise jump in UK inflation
17th Jan 2024 15:03
(Sharecast News) - London's financial markets experienced a downturn on Wednesday, as a surprising increase in UK inflation and sluggish Chinese GDP growth impacted investor sentiment.
Read moreBofA Merrill Lynch lifts Smith & Nephew price target
17th Jan 2024 12:46
(Sharecast News) - Bank of America Merrill Lynch upped its price target on Smith & Nephew on Wednesday to 1,320p from 1,180p.
Read moreBofA Merrill Lynch lifts Smith & Nephew price target
17th Jan 2024 12:46
(Sharecast News) - Bank of America Merrill Lynch upped its price target on Smith & Nephew on Wednesday to 1,320p from 1,180p.
Read moreSmith & Nephew wraps up $330m purchase of Israeli medtech firm CartiHeal
10th Jan 2024 07:27
(Sharecast News) - Medtech giant Smith + Nephew has completed the acquisition of CartiHeal, the developer of novel sports medicine technology Agili-C, which targets cartilage regeneration in the knee.
Read moreSmith & Nephew names new audit committee lead
6th Dec 2023 07:47
(Sharecast News) - Smith & Nephew has announced that non-executive director Rick Medlock has decided to step down after three years at the medical technology group.
Read moreGoldman starts Smith & Nephew at 'buy', cites improving fundamentals
10th Nov 2023 09:36
(Sharecast News) - Goldman Sachs initiated coverage of Smith & Nephew on Friday with a 'buy' rating and 1,400p price target, as it pointed to improving fundamentals and an undemanding valuation.
Read moreJPMorgan upgrades Smith & Nephew, says recent de-rating 'overdone'
3rd Nov 2023 09:19
(Sharecast News) - JPMorgan Cazenove upgraded Smith & Nephew to 'overweight' from 'neutral' on Friday as it argued the recent de-rating was overdone.
Read moreLondon close: Stocks rise as BoE keeps rates steady
2nd Nov 2023 15:12
(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.
Read moreSmith & Nephew expects strong full-year results after solid Q3
2nd Nov 2023 07:20
(Sharecast News) - Smith & Nephew has said that sales growth is now expected to be at the top end of guidance after a strong third quarter, though it did warn that margins would likely not grow as much as hoped.
Read moreBroker tips: Antofagasta, Spirax-Sarco, Smith & Nephew
10th Aug 2023 12:01
(Sharecast News) - Canaccord Genuity has maintained its 'buy' recommendation on miner Antofagasta despite the firm cutting its output forecasts on Thursday.
Read moreMajor upside potential at Smith & Nephew, says Berenberg
10th Aug 2023 11:07
(Sharecast News) - Berenberg has kept its 'buy' rating on Smith & Nephew after the medical equipment manufacturer's first-half results last week, giving an optimistic take on its current turnaround strategy.
Read more